Apposite Healthcare II GP LLP is a Londonbased general partner entity that plays a pivotal role in managing a healthcarefocused private equity fund. Incorporated in September 2015, this LLP partners with investment professionals to drive strategic decisions and oversee the fund’s portfolio companies across diagnostics, medtech, outpatient services, and health IT. While the name may suggest a narrow focus, the fund’s reach spans multiple subsectors of the European healthcare market, deploying capital and expertise to accelerate growth and improve healthcare delivery.
Formation and Legal Structure
Apposite Healthcare II GP LLP was officially registered with the UK’s Companies House on 16 September 2015, under company number OC401816.
Role of General Partner in Private Equity
In private equity terms, the GP (general partner) is the active manager. Apposite Healthcare II GP LLP sources deals, conducts due diligence, structures transactions, and collaborates with portfolio company leadership teams. Its responsibilities include monitoring performance, guiding strategic initiatives, and preparing exits such as trade sales or secondary listings on behalf of the fund.
Key Responsibilities of Apposite Healthcare II GP LLP
- Deal origination and screening within healthcare segments
- Due diligence on clinical, technical, financial, and regulatory aspects
- Negotiating terms and structuring equity investments
- Board representation and strategic oversight for portfolio companies
- Exit planning and execution to deliver returns to investors
- Ensuring regulatory compliance and governance
Backing from Apposite Capital
Apposite Healthcare II GP LLP operates under the umbrella of Apposite Capital LLP, a specialist healthcare investor focused on European investments.
Apposite Capital’s Investment Profile
- 19 years of experience in healthcare investing
- 29 prior investments and 40 + bolton acquisitions
- Use of seniorlevel advisors with clinical and commercial expertise
- Impactoriented approach, emphasizing improved access and innovation
Fund Focus and Sector Themes
Apposite Healthcare Fund II, managed by the GP LLP, targets midmarket European healthcare companies. The fund typically backs management buyouts, growth capital, and consolidation plays. PitchBook notes that the fund invests in services and life sciences businesses, with deal sizes ranging from GBP 1020 million.
Target SubSectors
- Diagnostic laboratories and genetic testing
- Medical device manufacturers
- Technologyenabled outpatient and home care services
- Specialist healthcare IT and software platforms
Fund Size and Capital Structure
According to the firm’s SEC Form D filing, Apposite Healthcare Fund II L.P. began fundraising in 2018 and raised an initial USD 2.34 million, with the potential for indefinite growth..
Governance and Regulatory Oversight
Apposite Healthcare II GP LLP is regulated as part of a private equity fund structure. It must comply with UK LLP regulations and UK/EU fund rules. The broader Apposite Capital entity is FCA-regulated in the UK.
Impact and ESG Framework
Apposite emphasizes an ‘impact and ESG’ (Environmental, Social, Governance) orientation, especially in healthcare. It aims not only to create financial returns but to deliver measurable improvements in service quality, accessibility, and innovation.
Examples of ESG Focus
- Supporting highquality diagnostic access
- Scaling efficient outpatient services
- Encouraging diversity and governance best practices
Related Entities and CoInvestment
Apposite Healthcare CoInvestment II L.P. is a separate but related limited partnership that allows LPs and other strategic investors to coinvest alongside the main fund. The GP LLP acts as a general partner for both the primary fund and coinvestment vehicles.
Why Apposite Healthcare II GP LLP Matters
This LLP represents the operational heart of Apposite’s strategy. It drives deal execution, portfolio oversight, and governance. Its role ensures that investments follow a consistent healthcarefocused approach combining financial discipline, sector experience, and impact objectives.
Apposite Healthcare II GP LLP is a key piece in a broader healthcare private equity ecosystem. As the managing partner of Fund II, it spearheads investment activity in diagnostics, medtech, healthcare services, and digital health across Europe. The entity is backed by the experienced Apposite Capital team, regulated by the FCA, and aligned with ESG principles. For investors and sector participants, understanding the GP LLP’s role helps clarify how this fund blends capital, operational support, and ethical focus to shape the future of healthcare businesses.
: